Management and clinical care
What the clinical literature supports — physiotherapy mainstay, pain management, anesthetic and surgical cautions — with evidence tiers made explicit.
Clinical guidance positions individualized physical therapy — strengthening, proprioceptive work, pacing — as the primary management for hEDS/HSD. The honest limitation: the trial record is small and heterogeneous; the recommendation rests on expert consensus and cohort experience more than large trials.
Local anesthetic resistance — the index's reference convergence
establishedpracticestrata convergecautionPatients reported local-anesthetic failure for decades. Hakim and Grahame's 2005 survey found 58% of hypermobile patients reported inadequate anesthesia vs 21% of controls; a 2019 survey (n=988) found 88% vs 33%; in 2025 a randomized cross-over trial (n=135) confirmed shorter lidocaine duration in EDS patients. The arc — forum reports, structured survey, randomized confirmation — is the model this index exists to document.
Chopra et al.'s 2017 management paper remains the reference for EDS pain care — multimodal analgesia, physiotherapy, psychological support, and caution about long-term opioids. Evidence tiers here are low: mostly expert consensus and small series.
Tissue fragility, wound-healing complications, and — in vEDS — arterial rupture risk make surgery a deliberate decision. The 2017 orthopaedic guidance favors conservative management; the record is cautious rather than prohibitionist.
The diagnostic-odyssey literature documents medical gaslighting and post-traumatic stress in hEDS patients; management guidance includes psychological support. The 2025 BMJ phenomenological study urges trauma-informed care at the point of diagnosis.